[1] M. W. Schwartz and D. Porte Jr., “Diabetes, obesity, and the brain,” Science, vol. 307, no. 5708, pp. 375–379, 2005.
[2] J. J. Hillebrand and N. Geary, “Do leptin and insulin signal adiposity?” Forum of Nutrition, vol. 63, pp. 111–122, 2010.
[3] J. F. Davis, D. L. Choi, and S. C. Benoit, “Insulin, leptin and reward,” Trends in Endocrinology and Metabolism, vol. 21, no. 2, pp. 68–74, 2010.
[4] G. J. Morton, “Hypothalamic leptin regulation of energy homeostasis and glucose metabolism,” Journal of Physiology, vol. 583, no. 2, pp. 437–443, 2007.
[5] T. Ronti, G. Lupattelli, and E. Mannarino, “The endocrine function of adipose tissue: an update,” Clinical Endocrinology, vol. 64, no. 4, pp. 355–365, 2006.
[6] D. J. Dyck, “Adipokines as regulators of muscle metabolism and insulin sensitivity,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 396–402, 2009.
[7] C. M. Steppan, S. T. Bailey, S. Bhat et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001.
[8] L. K. Heilbronn, J. Rood, L. Janderova et al., “Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 4, pp. 1844–1848, 2004.
[9] D. J. Dyck, G. J. F. Heigenhauser, and C. R. Bruce, “The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity,” Acta Physiologica, vol. 186, no. 1, pp. 5–16, 2006.
[10] F. Savino, M. F. Fissore, E. C. Grassino, G. E. Nanni, R. Oggero, and L. Silvestro, “Ghrelin, leptin and IGF-I levels in breast-fed and formula-fed infants in the first years of life,” Acta Paediatrica, vol. 94, no. 5, pp. 531–537, 2005.
[11] Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994.
[12] H. Masuzaki, Y. Ogawa, N. Sagawa et al., “Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans,” Nature Medicine, vol. 3, no. 9, pp. 1029–1033, 1997.
[13] S. M. Smith-Kirwin, D. M. O’Connor, J. Johnston, E. De Lancey, S. G. Hassink, and V. L. Funanage, “Leptin expression in human mammary epithelial cells and breast milk,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 5, pp. 1810–1813, 1998.
[14] F. Savino, S. A. Liguori, E. Petrucci et al., “Evaluation of leptin in breast milk, lactating mothers and their infants,” European Journal of Clinical Nutrition, vol. 64, pp. 972–977, 2010.
[15] G. Frühbeck, S. A. Jebb, and A. M. Prentice, “Leptin: physiology and pathophysiology,” Clinical Physiology, vol. 18, no. 5, pp. 399–419, 1998.
[16] M. K. Sinha, J. P. Ohannesian, M. L. Heiman et al., “Nocturnal rise of leptin in lean, obese, and non-insulin- dependent diabetes mellitus subjects,” Journal of Clinical Investigation, vol. 97, no. 5, pp. 1344–1347, 1996.
[17] V. Anubhuti and S. Arora, “Leptin and its metabolic interac- tions - An update,” Diabetes, Obesity and Metabolism, vol. 10, no. 11, pp. 973–993, 2008.
[18] C. De Graaf, W. A. M. Blom, P. A. M. Smeets, A. Stafleu, and H. F. J. Hendriks, “Biomarkers of satiation and satiety,” American Journal of Clinical Nutrition, vol. 79, no. 6, pp. 946– 961, 2004.
[19] S. H. Bates, W. H. Stearns, T. A. Dundon et al., “STAT3 signalling is required for leptin regulation of energy balance but not reproduction,” Nature, vol. 421, no. 6925, pp. 856– 859, 2003.
[20] K. D. Niswender, G. J. Morton, W. H. Stearns, C. J. Rhodes, M. G. Myers, and M. W. Schwartz, “Intracellular signalling: key enzyme in leptin-induced anorexia,” Nature, vol. 413, no. 6858, pp. 794–795, 2001.
[21] K. Rahmouni, “Brain effects of leptin: what intracellular mechanism?” Current Diabetes Reports, vol. 3, no. 6, pp. 427– 429, 2003.
[22] P. J. Scarpace, M. Matheny, B. H. Pollock, and N. Tümer, “Leptin increases uncoupling protein expression and energy expenditure,” American Journal of Physiology, vol. 273, no. 1, pp. E226–E230, 1997.
[23] R. Gutiérrez-Juárez, S. Obici, and L. Rossetti, “Melanocortin- independent effects of leptin on hepatic glucose fluxes,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 49704– 49715, 2004.
[24] J. A. Cases, I. Gabriely, X. H. Ma et al., “Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo,” Diabetes, vol. 50, no. 2, pp. 348–352, 2001.
[25] H. Dhillon, S. P. Kalra, V. Prima et al., “Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study,” Regulatory Peptides, vol. 99, no. 2-3, pp. 69–77, 2001.
[26] T. J. Kieffer and J. F. Habener, “The adipoinsular axis: effects of leptin on pancreatic β-cells,” American Journal of Physiology, vol. 278, no. 1, pp. E1–E14, 2000.
[27] Y. Minokoshi, Y. B. Kim, O. D. Peroni et al., “Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase,” Nature, vol. 415, no. 6869, pp. 339–343, 2002.
[28] I. Sadaf Farooqi, G. Matarese, G. M. Lord et al., “Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency,” Journal of Clinical Investigation, vol. 110, no. 8, pp. 1093–1103, 2002.
[29] L. L. Sweeney, A. M. Brennan, and C. S. Mantzoros, “The role of adipokines in relation to HIV lipodystrophy,” AIDS, vol. 21, no. 8, pp. 895–904, 2007.
[30] J. Sánchez, P. Oliver, O. Miralles, E. Ceresi, C. Pic o,  ́ and A. Palou, “Leptin orally supplied to neonate rats is directly uptaken by the immature stomach and may regulate short- term feeding,” Endocrinology, vol. 146, no. 6, pp. 2575–2582, 2005.
[31] C. Pic o,  ́ P. Oliver, J. Sánchez et al., “The intake of physiological doses of leptin during lactation in rats prevents obesity in later life,” International Journal of Obesity, vol. 31, no. 8, pp. 1199–1209, 2007.
[32] J. Sánchez, T. Priego, M. Palou, A. Tobaruela, A. Palou, and C. Pic o,  ́ “Oral supplementation with physiological doses of leptin during lactation in rats improves insulin sensitivity and affects food preferences later in life,” Endocrinology, vol. 149, no. 2, pp. 733–740, 2008.
[33] I. S. Farooqi, S. A. Jebb, G. Langmack et al., “Effects of recombinant leptin therapy in a child with congenital leptin deficiency,” New England Journal of Medicine, vol. 341, no. 12, pp. 879–884, 1999.
[34] K. El-Haschimi and H. Lehnert, “Leptin resistance - Or why leptin fails to work in obesity,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 1, pp. 2–7, 2003.
[35] A. H. F. Bakker, F. M. H. Van Dielen, J. W. M. Greve, J. A. Adam, and W. A. Buurman, “Preadipocyte number in omen- tal and subcutaneous adipose tissue of obese individuals,” Obesity Research, vol. 12, no. 3, pp. 488–498, 2004.
[36] H. Christou, S. Serdy, and C. S. Mantzoros, “Leptin in relation to growth and developmental processes in the fetus,” Seminars in Reproductive Medicine, vol. 20, no. 2, pp. 123– 129, 2002.
[37] S. G. Bouret, S. J. Draper, and R. B. Simerly, “Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding,” Science, vol. 304, no. 5667, pp. 108–110, 2004.
[38] P. C. Ng, C. W. K. Lam, C. H. Lee et al., “Changes of leptin and metabolic hormones in preterm infants: a longitudinal study in early postnatal life,” Clinical Endocrinology, vol. 54, no. 5, pp. 673–680, 2001.
[39] P. S. Shekhawat, J. S. Garland, C. Shivpuri et al., “Neonatal cord blood leptin: its relationship to birth weight, body mass index, maternal diabetes, and steroids,” Pediatric Research, vol. 43, no. 3, pp. 338–343, 1998.
[40] H. A. Koistinen, V. A. Koivisto, S. Andersson et al., “Leptin concentration in cord blood correlates with intrauterine growth,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 10, pp. 3328–3330, 1997.